Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07328516 | Natural History Study of Early Life Exposures in Agriculture (ELEA) | enrolling by invitation | — | 64,277 | National Cancer Institute (NCI)NIH | 1 | Sep 29, 2026 | clinicaltrials |
| NCT00068003 | Harvesting Cells for Experimental Cancer Treatments | enrolling by invitation | — | 7,000 | National Cancer Institute (NCI)NIH | 1 | Sep 28, 2026 | clinicaltrials |
| NCT03762733 | Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies | enrolling by invitation | — | 500 | National Cancer Institute (NCI)NIH | 1 | Sep 28, 2026 | clinicaltrials |
| NCT05645536 | Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study | enrolling by invitation | Phase 3 | 250 | Tolmar Inc.INDUSTRY | 6 | Sep 1, 2026 | clinicaltrials |
| NCT07798466 | Immediate Autologous Tissue Breast Reconstruction and Radiotherapy Strategy After Breast Cancer Surgery | enrolling by invitation | — | 128 | Fudan UniversityOTHER | 1 | Sep 1, 2026 | clinicaltrials |
| NCT06910072 | Paclitaxel Polymeric Micelles and Carboplatin in Combination With Iparomilimab and Tuvonralimab Neoadjuvant Therapy for Triple-negative Breast Cancer（UPGRADE-TNBC）(UPGRADE-TNBC) | enrolling by invitation | Phase 2 / Phase 3 | 32 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Aug 18, 2026 | clinicaltrials |
| NCT06680596 | Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd Therapy(SAFIR3LibHERty) | enrolling by invitation | Phase 2 | 80 | UNICANCEROTHER | 1 | Aug 3, 2026 | clinicaltrials |
| NCT07651345 | Trial to Evaluate the Impact of Various Pragmatic Interventions to Increase Mammography Uptake Among Defaulted Repeat Screeners in Singapore(REMIND1) | enrolling by invitation | N/A | 12,750 | National University Hospital, SingaporeOTHER | 1 | Jun 16, 2026 | clinicaltrials |
| NCT07644845 | MammoVerse: Clinicians Focus Group | enrolling by invitation | — | 12 | University of Central FloridaOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT07218003 | A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4 | enrolling by invitation | Phase 1 | 149 | Rondo TherapeuticsINDUSTRY | 1 | Jun 11, 2026 | clinicaltrials |
| NCT06885424 | A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products(DESCENT-1) | enrolling by invitation | — | 400 | A2 Biotherapeutics Inc.INDUSTRY | 1 | May 20, 2026 | clinicaltrials |
| NCT07298980 | ExBRAC- Expressive Writing in Breast Cancer(ExBRAC) | enrolling by invitation | N/A | 272 | Region SkaneOTHER | 1 | May 13, 2026 | clinicaltrials |
| NCT05486520 | Low-field MRI for Breast Cancer Screening | enrolling by invitation | N/A | 40 | Massachusetts General HospitalOTHER | 1 | May 12, 2026 | clinicaltrials |
| NCT05400941 | Aim 3, Adapting and Implementing Evidence-based Breast Cancer Follow-up in Primary Care | enrolling by invitation | N/A | 910 | Rutgers, The State University of New JerseyOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT07549685 | Music Therapy in Patients With Breast Cancer (IMPACT)(IMPACT-) | enrolling by invitation | N/A | 24 | Istituto di Studi Superiori Musicali (ISSM) Conservatorio Antonio Vivaldi di AlessandriaOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT05876390 | Impact of Regional Anesthesia on Chronic Post-operative Pain(IRACPoP) | enrolling by invitation | — | 1,500 | Niguarda HospitalOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT07514728 | Concept-verification Clinical Trial on the Inhibition of Breast Cancer Lung Metastasis Progression by Hyperbaric Oxygen(HBOIBCLM) | enrolling by invitation | N/A | 10 | Jinan Central HospitalOTHER | 1 | Apr 7, 2026 | clinicaltrials |
| NCT07483034 | Receptive Music Therapy Effects on Anxiety, Depression, QoL, and EGF, IL-8, and NfL During the Breast Cancer Treatment. | enrolling by invitation | N/A | 90 | Brigita VilcOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT06650748 | Multigene Risk Score Combined With Ki-67 Dynamic Assessment in Stratified Neoadjuvant Endocrine Therapy Treatment With or Without CDK4/6 Inhibitors in HR+/HER2- Breast Cancer(NeoMARS) | enrolling by invitation | Phase 2 | 100 | Peking UniversityOTHER | 1 | Mar 17, 2026 | clinicaltrials |
| NCT07465497 | Impact of Supplementation With Synbiotics and Prebiotics on Cognitive Decline Associated With Neoadjuvant Chemotherapy in First-line Patients With Breast Cancer | enrolling by invitation | N/A | 80 | Instituto Jalisciense de CancerologiaOTHER_GOV | 1 | Mar 12, 2026 | clinicaltrials |
| NCT05160480 | A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG | enrolling by invitation | — | 9 | University of California, DavisOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT07080463 | Application of VascuLens 2.0, A Mixed Reality System for Surgical Guidance During DIEP Flap Harvest(VascuLens RCT) | enrolling by invitation | Phase 1 | 60 | University of British ColumbiaOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT07049822 | Optimising Mammography Screening Accuracy With Blood-based Biomarkers(OPTIMA) | enrolling by invitation | — | 1,200 | Vejle HospitalOTHER | 1 | Mar 9, 2026 | clinicaltrials |
| NCT04996316 | MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals | enrolling by invitation | — | 1,141 | OHSU Knight Cancer InstituteOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT07409298 | Impact of an Artificial Intelligence-Based Management Model on Psychological and Behavioral Outcomes in Breast Cancer Patients Undergoing Home CDK4/6 Inhibitor Therapy | enrolling by invitation | N/A | 300 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT01173341 | Cardiotoxicity of Cancer Therapy (CCT) | enrolling by invitation | — | 700 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT06332131 | Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature | enrolling by invitation | — | 25 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT07376629 | A Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC | enrolling by invitation | Phase 2 | 60 | Huabo Biopharm Co., Ltd.INDUSTRY | 1 | Jan 29, 2026 | clinicaltrials |
| NCT07376681 | Fertility Outcomes In Young Breast Cancer Patients And Their Prognosis And Offspring Health | enrolling by invitation | — | 2,000 | Taizhou HospitalOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT07359404 | Sacituzumab Govitecan Plus Bevacizumab in Metastatic TNBC | enrolling by invitation | Phase 2 | 60 | YING FANOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT07352137 | Endoscopic Nipple-Sparing Mastectomy (E-NSM) With Immediate Multistage Autologous Fat Grafting(IMAFG) for Total Breast Reconstruction Via the Axillary Incision | enrolling by invitation | N/A | 20 | Guangdong Provincial Hospital of Traditional Chinese MedicineOTHER | 1 | Jan 20, 2026 | clinicaltrials |
| NCT07306130 | Consensus on Skin Care in Breast Cancer Patients | enrolling by invitation | — | 15 | Venus Research CenterOTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT07100054 | Pharmacogenomic and Circulating Biomarkers for CDK4/6 Inhibitors | enrolling by invitation | — | 100 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Dec 12, 2025 | clinicaltrials |
| NCT06843681 | Trastuzumab Plus Taxane Neoadjuvant Therapy for HER2-Positive Breast Ductal Carcinoma In Situ (DCIS) : A Phase II Study | enrolling by invitation | Phase 2 | 54 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Nov 28, 2025 | clinicaltrials |
| NCT07206888 | Advanced Ultrasound Signal Processing of Suspicious Breast Images(AUSPICIOUS) | enrolling by invitation | — | 252 | Johns Hopkins UniversityOTHER | 1 | Oct 14, 2025 | clinicaltrials |
| NCT06391749 | Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)(K-ACCELERATE) | enrolling by invitation | — | 1,000 | Gene SolutionsINDUSTRY | 1 | Jul 16, 2025 | clinicaltrials |
| NCT07056205 | Comparative Expression of ER,PR and HER2/Neu in Initial and Recurrent Breast Cancer. | enrolling by invitation | — | 100 | Sohag UniversityOTHER | 1 | Jul 9, 2025 | clinicaltrials |
| NCT07023848 | PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors | enrolling by invitation | Early Phase 1 | 10 | Affiliated Hospital of Jiangnan UniversityOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT07023861 | The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies | enrolling by invitation | Early Phase 1 | 20 | Affiliated Hospital of Jiangnan UniversityOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT06958445 | Prevention of Oral Mucositis and Improvement of Quality of Life for Patients With Breast Cancer Undergoing Adjuvant Radiotherapy(SAFE) | enrolling by invitation | Phase 2 | 90 | Taipei City HospitalOTHER_GOV | 1 | May 6, 2025 | clinicaltrials |
| NCT06943313 | Breast Cancer PET/CT Imaging With 68Ga-pAKTi | enrolling by invitation | — | 20 | Fudan UniversityOTHER | 1 | Apr 24, 2025 | clinicaltrials |
| NCT04098640 | Molecular Profiling in Young (<50 Years of Age) Patients With Metastatic Breast Cancer | enrolling by invitation | N/A | 200 | Seoul National University HospitalOTHER | 1 | Apr 17, 2025 | clinicaltrials |
| NCT06223022 | Nurse-led Proactive Telephone Follow-up With Patients After Completion of Primary Cancer Treatment | enrolling by invitation | N/A | 512 | Umeå UniversityOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT06890871 | Radiotherapy with Immunotherapy and Anti-Angiogenic Therapy for Advanced HER2-Negative Breast Cancer: a Single-Arm Study | enrolling by invitation | Phase 1 / Phase 2 | 25 | Zhongnan HospitalOTHER | 1 | Mar 24, 2025 | clinicaltrials |
| NCT06881550 | Real-world Study on Shenbailing Granules for Improving Qi and Blood Deficiency in Patients After Breast Cancer Surgery | enrolling by invitation | N/A | 2,000 | Caigang LiuOTHER | 1 | Mar 18, 2025 | clinicaltrials |
| NCT06447532 | Use of Machine Learning Techniques for Serial Assessment of Systemic Inflammatory Markers in Breast Cancer Patients(INFLAMMATE) | enrolling by invitation | — | 4,500 | Federal University of São PauloOTHER | 8 | Mar 12, 2025 | clinicaltrials |
| NCT06405295 | Intensive Adjuvant Therapy for TNBC with BRCA Gene Mutation | enrolling by invitation | — | 600 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT06793306 | A Study Comparing the Differences Between Young and Non-young Breast Cancer | enrolling by invitation | — | 3,000 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT06828614 | Barriers to Therapeutic Exercise in Breast Cancer Patients Before, During, and After Chemotherapy | enrolling by invitation | — | 111 | University of ValenciaOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT06821490 | Validation of TAD in HER-2 with More Than 2 Lymph Nodes(DAD-HER2) | enrolling by invitation | — | 21 | Fundación para la Investigación del Hospital Clínico de ValenciaOTHER | 1 | Feb 12, 2025 | clinicaltrials |
Data updated 14 hours agoSource updated Sep 29, 2026source: clinicaltrials